Risk Factors of Atrial Fibrillation After Cardiac Surgery

NCT07625033 | Not Yet Recruiting

• 1 other identifier: 2026-03-Obs-CHRMT
• Study Type: observational
• Target: 918
• Locations: 1 country
• Sites: 1

Brief Summary

Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.

Conditions

Cardiac Surgery; Peri Operative Medicine; Thoracic Surgery; Cardiopulmonary Bypass; Coronary Artery Bypass; Aortic Valve Replacement; Perioperative Medicine; Intraoperative Care; Enhanced Recovery After Surgery; Anesthesia; Cardiac Anesthesia; Intensive Care Unit; Heart Valve Prosthesis Implantation; Postoperative Care; Preoperative Care

Keywords

Stellar Ganglion Blockade, SGB, cardiac surgery

Outcome Measures

Primary Outcomes (1)

• Occurrence of postoperative atrial fibrillation

  monitor on cardiac ECG monitoring performed during the routine cares in cardiac ICU

  from cardiac surgery (day 0) up to ICU discharge (about 3 days on average)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients having undergone a scheduled cardiac surgery in the study center and having agreed to the reuse of their hospital care data

You may qualify if:

• age \>18
• having undergone a scheduled cardiac surgery in the study center
• having agreed to the reuse of their hospital care data

You may not qualify if:

• Atrial fibrillation at the admission in hospital.

Sponsors & Collaborators

• Centre Hospitalier Régional Metz-Thionville: lead

Study Sites (1)

CHR Metz-Thionville Hopital de Mercy

Metz, France, 57085, France

Location

MeSH Terms

Conditions

Simpson-Golabi-Behmel syndrome

Central Study Contacts

Mickael LESCROART

CONTACT

+33387186632; mickael.lescroart@chr-metz-thionville.fr

Andreia CARVALHO DE FREITAS

CONTACT

+33387553323; projet-recherche-clinique@chr-metz-thionville.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 29, 2026
• First Posted: June 4, 2026
• Study Start: June 1, 2026
• Primary Completion: June 1, 2026
• Study Completion: June 1, 2026
• Last Updated: June 12, 2026

Record last verified: 2026-06

Data Sharing

• IPD Sharing: Will not share

Locations

FR (1)